Non-Alcoholic Fatty Liver Disease Have Patients with Comorbidities: the Experience of Therapy with the Use of Thiotriazolin
The article describes the pathogenesis and possible methods of therapy of nonalcoholic fatty liver disease, including in the group of comorbid patients. The mechanisms of Thiotriazoline action in NAFLD patients are examined. We present clinical cases of a positive impact of Thiotriazoline in NAFLD patients.